Daisuke Matsui

Predictors of continuation for asenapine from real-world data in patients with schizophrenia

Y. Koshikawa, Y. Takekita, Nobuatsu Aoki, 2024, Annals of general psychiatry.

Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data

Y. Koshikawa, Y. Takekita, Nobuatsu Aoki, 2023, Neuropsychopharmacology reports.